πŸ‡ΊπŸ‡Έ FDA
Patent

US 7314911

Prostate hyperplasia therapy

granted A61KA61K38/28

Quick answer

US patent 7314911 (Prostate hyperplasia therapy) held by The Board of Regents of the University of Texas System expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K38/28